发明名称 (-)-5-(3-Chlorophenyl)-ec-(4-chlorophenyl)-oc-(1-methyl-lH-imidazol-5-yl)- tetrazolo [1,5-a] quinazoline-7-methanamine a farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
摘要 Disclosed herein is a farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer such as (-)-5-(3-Chlorophenyl)-a-(4-chlorophenyl)-a-(1-methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts, and the use of such compounds in medicine especially for the treatment of cancer.
申请公布号 NZ522481(A) 申请公布日期 2004.09.24
申请号 NZ20010522481 申请日期 2001.06.13
申请人 JANSSEN PHARMACEUTICA N 发明人 VENET, MARC GASTON;ANGIBAUD, PATRICK RENE;END, DAVID WILLIAM
分类号 A61K31/519;A61P35/00;C07D487/04;(IPC1-7):C07D487/04 主分类号 A61K31/519
代理机构 代理人
主权项
地址